• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

April 15, 2019
Company Drug/Device Medical Condition Status
Immatics IMA203 solid tumors Phase I trial initiated enrolling 15 subjects with relapsed and/or refractory solid tumors for which no standard of care therapy is available
Concert Pharmaceuticals, Inc. CTP-692 schizophrenia Phase I trial initiated
National Institutes of Health (NIH) H1ssF_3928 flu Phase I trial initiated
Synchron, Inc. Stentrode in combination with BrainOS software severe paralysis Phase I trial initiated taking place at hospitals in Melbourne, Australia
Homology Medicines, Inc. HMI-102 phenylketonuria (PKU) Phase I/II trial initiated enrolling adults aged 18 to 55 years
NanOlogy NanoDoce (sterile submicron particle docetaxel suspension) bladder cancer Phase I/II trial initiated
Provention Bio, Inc. PRV-031 (teplizumab) recent onset type 1 diabetes (T1D) Phase III trial initiated enrolling 300 subjects aged 8-17 years with recent onset T1D at 80 centers worldwide
Pfizer IBRANCE (palbociclib) men with HR+, HER2- metastatic breast cancer sNDA approval granted by the FDA
Synspira Therapeutics SNSP113 cystic fibrosis (CF) Orphan Drug designation granted by the EMA
Aggredyne, Inc. AggreGuide A 100 ADP Assay testing cartridge platelet testing technologies Clearance granted by the FDA
Spry Health Loop System chronic obstructive pulmonary disease (COPD) Clearance granted by the FDA
Viiv Healthcare Dovato (combination of dolutegravir (DTG) and lamivudine (3TC)) HIV-1 in adults who had not received treatment before Approval granted by the FDA
Amgen Evenity (romosozumab-aqqg) osteoporosis in postmenopausal women at high risk of breaking a bone (fracture) Approval granted by the FDA

 

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing